Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

Clemens Becker(Robert Bosch Hospital), Stephen R. Lord(UNSW Sydney), Stephanie A. Studenski(University of Pittsburgh), Stuart J. Warden(Indiana University Health), Roger A. Fielding(Tufts University), Christopher Recknor(Bone Health and Osteoporosis Foundation), Marc C. Hochberg(University of Maryland, Baltimore), Serge Ferrari(University Hospital of Geneva), Hubert Blain(Centre Hospitalier Universitaire de Montpellier), Ellen F. Binder(Washington University in St. Louis), Yves Rolland(Centre Hospitalier Universitaire de Toulouse), Serge Poiraudeau(Université Paris Cité), Charles Benson(Eli Lilly (United States)), Stephen L. Myers(Eli Lilly (United States)), Leijun Hu(Eli Lilly (United States)), Qasim Ahmad(Eli Lilly (United States)), Kelli R Pacuch(Eli Lilly (United States)), Elisa V Gomez(Eli Lilly (United States)), Olivier Bénichou
The Lancet Diabetes & Endocrinology
October 27, 2015
Cited by 365

Abstract


Related Papers

No related papers found

Powered by citation graph analysis